Immunothrombosis in COVID-19–associated Coagulopathy Webinar
COVID-19 is characterized by multi-organ involvement with micro- and macrovascular thrombotic complications. Mechanistically, activated platelets and monocytes lead to neutrophilic vascular inflammation and immunothrombosis, linking coagulopathy with disease severity.
- COVID-19 and Coagulopathy
- VTE
- Anticoagulant therapy
- Pathophysiology
- Thrombosis
- Coagulopathy and COVID-19
- covid-19 microthrombosis
- thromboinflammation covid-19
- thrombosis prophylaxis guidelines vte prophylaxis
- microclots with covid
- hypercoagulability of covid-19
